Tie-ups with Aurobindo Pharma give customers the competitive edge through faster product development and optimized costs.
Annual sales growth of pharmaceuticals in the emerging markets is already in double-digit, providing a key opportunity for many MNCs to foray into Generics. Revenue streams in these markets can be derived from branded off-patent drugs, branded generics, and local brands owned or licensed by the acquiring pharma company. The number of in-licensing deals is increasing over recent years and all MNCs are actively seeking acquisitions and licensing agreements as a more cost-effective means of gaining access to Generics, and novel products than carrying out extensive in-house R&D.
Aurobindo Pharma's strategy is based on co-working and collaborative alliances with the world's majors and the company has very successfully established strategic partnerships and out licensed close to 200 products with pharma majors.
Aurobindo has evolved into a knowledge driven...Strategic Alliance
Our Corporate Social Responsibility includes...Social Responsibility
Aurobindo Pharma has a team of more than...Global Family
Financial Results of Aurobindo Pharma...Investor Relations